{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:35:57Z","timestamp":1793957757171,"version":"4.8.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1038\/s41582-026-01249-0","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:14:11Z","timestamp":1785755651000},"page":"652-660","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Towards a biologically informed description of multiple sclerosis disease course \u2014 a roadmap for transition"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4333-8496","authenticated-orcid":false,"given":"Alan J.","family":"Thompson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5722-0475","authenticated-orcid":false,"given":"Fred D.","family":"Lublin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4059-9108","authenticated-orcid":false,"given":"Lindsay","family":"Rechtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3325-3760","authenticated-orcid":false,"given":"Maria Pia","family":"Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0941-9169","authenticated-orcid":false,"given":"Bruce","family":"Bebo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7776-6472","authenticated-orcid":false,"given":"Peter A.","family":"Calabresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0109-7698","authenticated-orcid":false,"given":"Julie","family":"Fiol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1774-4810","authenticated-orcid":false,"given":"Marcia","family":"Finlayson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1336-5899","authenticated-orcid":false,"given":"Annie","family":"Hawton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0174-5042","authenticated-orcid":false,"given":"Tanja","family":"Kuhlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth Ann","family":"Marrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Moccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Montalban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Panzara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9558-9038","authenticated-orcid":false,"given":"Kathy","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6892-104X","authenticated-orcid":false,"given":"Maria Pia","family":"Sormani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Strum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara G.","family":"Vickrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3031-7549","authenticated-orcid":false,"given":"Timothy","family":"Coetzee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the 2025 International Advisory Committee on Clinical Trials in Multiple Sclerosis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilyana","family":"Amezcua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Banwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Barkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Bar-Or","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Butzkueven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Chataway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Ciccarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Correale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Fujihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Granziera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Hellwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joep","family":"Killestein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorlan","family":"Kimbrough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"Kos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Lebrun-Fr\u00e9nay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwon","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ontaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudarshini","family":"Ramanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Reich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Salter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Stankoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Tintor\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Tremlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke","family":"van der Walt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Zaratin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"1249_CR1","doi-asserted-by":"publisher","first-page":"e1641","DOI":"10.1212\/WNL.0000000000012726","volume":"97","author":"M Tintore","year":"2021","unstructured":"Tintore, M. et al. Effect of changes in MS diagnostic criteria over 25 years on time to treatment and prognosis in patients with clinically isolated syndrome. Neurology 97, e1641\u2013e1652 (2021).","journal-title":"Neurology"},{"key":"1249_CR2","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1001\/jamaneurol.2019.0330","volume":"76","author":"O Beiki","year":"2019","unstructured":"Beiki, O., Frumento, P., Bottai, M., Manouchehrinia, A. & Hillert, J. Changes in the risk of reaching multiple sclerosis disability milestones in recent decades: a nationwide population-based cohort study in Sweden. JAMA Neurol. 76, 665\u2013671 (2019).","journal-title":"JAMA Neurol."},{"key":"1249_CR3","doi-asserted-by":"publisher","DOI":"10.1177\/13524585221140271","author":"D Jakimovski","year":"2022","unstructured":"Jakimovski, D. et al. Improvement in time to multiple sclerosis diagnosis: 25-year retrospective analysis from New York State MS Consortium (NYSMSC). Mult. Scler. https:\/\/doi.org\/10.1177\/13524585221140271 (2022).","journal-title":"Mult. Scler."},{"key":"1249_CR4","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1212\/WNL.46.4.907","volume":"46","author":"FD Lublin","year":"1996","unstructured":"Lublin, F. D., Reingold, S. C. & the National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 46, 907\u2013911 (1996).","journal-title":"Neurology"},{"key":"1249_CR5","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","volume":"83","author":"FD Lublin","year":"2014","unstructured":"Lublin, F. D. et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 83, 278\u2013286 (2014).","journal-title":"Neurology"},{"key":"1249_CR6","doi-asserted-by":"publisher","DOI":"10.1177\/13524585231196786","author":"AJ Thompson","year":"2023","unstructured":"Thompson, A. J. et al. Do the current MS clinical course descriptors need to change and if so how? A survey of the MS community. Mult. Scler. https:\/\/doi.org\/10.1177\/13524585231196786 (2023).","journal-title":"Mult. Scler."},{"key":"1249_CR7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","volume":"22","author":"T Kuhlmann","year":"2023","unstructured":"Kuhlmann, T. et al. Multiple sclerosis progression: time for a new mechanism-driven framework. Lancet Neurol. 22, 78\u201388 (2023).","journal-title":"Lancet Neurol."},{"key":"1249_CR8","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1007\/s10072-023-06838-1","volume":"44","author":"A Papathanasiou","year":"2023","unstructured":"Papathanasiou, A. et al. Real-world annualized relapse rates from contemporary multiple sclerosis clinics in the UK: a retrospective multicentre cohort study. Neurol. Sci. 44, 3629\u20133635 (2023).","journal-title":"Neurol. Sci."},{"key":"1249_CR9","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/ana.26281","volume":"91","author":"A Bischof","year":"2022","unstructured":"Bischof, A. et al. Spinal cord atrophy predicts progressive disease in relapsing multiple sclerosis. Ann. Neurol. 91, 268\u2013281 (2022).","journal-title":"Ann. Neurol."},{"key":"1249_CR10","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/ana.25463","volume":"85","author":"BAC Cree","year":"2019","unstructured":"Cree, B. A. C. et al. Silent progression in disease activity-free relapsing multiple sclerosis. Ann. Neurol. 85, 653\u2013666 (2019).","journal-title":"Ann. Neurol."},{"key":"1249_CR11","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2023.3331","author":"J Muller","year":"2023","unstructured":"Muller, J. et al. Harmonizing definitions for progression independent of relapse activity in multiple sclerosis: a systematic review. JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2023.3331 (2023).","journal-title":"JAMA Neurol."},{"key":"1249_CR12","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209444","volume":"103","author":"O Ciccarelli","year":"2024","unstructured":"Ciccarelli, O. et al. Using the progression independent of relapse activity framework to unveil the pathobiological foundations of multiple sclerosis. Neurology 103, e209444 (2024).","journal-title":"Neurology"},{"key":"1249_CR13","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1001\/jamaneurol.2025.0495","volume":"82","author":"J M\u00fcller","year":"2025","unstructured":"M\u00fcller, J. et al. Standardized definition of progression independent of relapse activity (PIRA) in relapsing-remitting multiple sclerosis. JAMA Neurol. 82, 614\u2013625 (2025).","journal-title":"JAMA Neurol."},{"key":"1249_CR14","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1212\/WNL.0000000000009636","volume":"94","author":"FD Lublin","year":"2020","unstructured":"Lublin, F. D. et al. The 2013 clinical course descriptors for multiple sclerosis: a clarification. Neurology 94, 1088\u20131092 (2020).","journal-title":"Neurology"},{"key":"1249_CR15","unstructured":"Drug approval package: Ocrevus (ocrelizumab) injection. US FDA https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2017\/761053Orig1s000TOC.html (2017)."},{"key":"1249_CR16","unstructured":"Committee for Medicinal Products for Human Use. Summary of opinion \u2013 Ocrevus. EMA https:\/\/www.ema.europa.eu\/en\/documents\/smop-initial\/chmp-summary-positive-opinion-ocrevus_en.pdf (2017)."},{"key":"1249_CR17","doi-asserted-by":"publisher","unstructured":"van der Walt, A. Patient voice: the label given to my MS disease course matters to me\u2014Commentary. Mult. Scler. https:\/\/doi.org\/10.1177\/13524585251396286 (2025).","DOI":"10.1177\/13524585251396286"},{"key":"1249_CR18","doi-asserted-by":"publisher","unstructured":"Strum, J. Patient voice: the label given to my MS disease course matters to me\u2014yes. Mult. Scler. https:\/\/doi.org\/10.1177\/13524585251396262 (2025).","DOI":"10.1177\/13524585251396262"},{"key":"1249_CR19","doi-asserted-by":"publisher","unstructured":"Smith, K. The label given to my MS disease course matters to me\u2014no. Mult. Scler. https:\/\/doi.org\/10.1177\/13524585251396264 (2025).","DOI":"10.1177\/13524585251396264"},{"key":"1249_CR20","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/S1474-4422(22)00120-X","volume":"21","author":"SJ Tabrizi","year":"2022","unstructured":"Tabrizi, S. J. et al. A biological classification of Huntington\u2019s disease: the integrated staging system. Lancet Neurol. 21, 632\u2013644 (2022).","journal-title":"Lancet Neurol."},{"key":"1249_CR21","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","volume":"23","author":"T Simuni","year":"2024","unstructured":"Simuni, T. et al. A biological definition of neuronal alpha-synuclein disease: towards an integrated staging system for research. Lancet Neurol. 23, 178\u2013190 (2024).","journal-title":"Lancet Neurol."},{"key":"1249_CR22","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr.","year":"2024","unstructured":"Jack, C. R. Jr. et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement. 20, 5143\u20135169 (2024).","journal-title":"Alzheimers Dement."},{"key":"1249_CR23","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/S1474-4422(25)00270-4","volume":"24","author":"X Montalban","year":"2025","unstructured":"Montalban, X. et al. Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Lancet Neurol. 24, 850\u2013865 (2025).","journal-title":"Lancet Neurol."},{"key":"1249_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22265-2","volume":"12","author":"A Eshaghi","year":"2021","unstructured":"Eshaghi, A. et al. Identifying multiple sclerosis subtypes using unsupervised machine learning and MRI data. Nat. Commun. 12, 2078 (2021).","journal-title":"Nat. Commun."},{"key":"1249_CR25","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.1038\/s41591-025-03901-6","volume":"31","author":"H Ganjgahi","year":"2025","unstructured":"Ganjgahi, H. et al. AI-driven reclassification of multiple sclerosis progression. Nat. Med. 31, 3414\u20133424 (2025).","journal-title":"Nat. Med."},{"key":"1249_CR26","doi-asserted-by":"publisher","first-page":"4578","DOI":"10.1093\/brain\/awaf331","volume":"148","author":"C Willard","year":"2025","unstructured":"Willard, C. et al. Combined magnetic resonance imaging and serum analysis reveals distinct multiple sclerosis types. Brain 148, 4578\u20134591 (2025).","journal-title":"Brain"},{"key":"1249_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000001262","author":"S Krieger","year":"2024","unstructured":"Krieger, S., Cook, K. & Hersh, C. M. Understanding multiple sclerosis as a disease spectrum: above and below the clinical threshold. Curr. Opin. Neurol. https:\/\/doi.org\/10.1097\/WCO.0000000000001262 (2024).","journal-title":"Curr. Opin. Neurol."},{"key":"1249_CR28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/qjmed\/21.2.135","volume":"21","author":"AD Mc","year":"1952","unstructured":"Mc, A. D. & Compston, N. Some aspects of the natural history of disseminated sclerosis. Q. J. Med. 21, 135\u2013167 (1952).","journal-title":"Q. J. Med."},{"key":"1249_CR29","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/S1474-4422(25)00275-3","volume":"24","author":"S Saidha","year":"2025","unstructured":"Saidha, S. et al. The use of optical coherence tomography and visual evoked potentials in the 2024 McDonald diagnostic criteria for multiple sclerosis. Lancet. Neurol. 24, 880\u2013892 (2025).","journal-title":"Lancet. Neurol."},{"key":"1249_CR30","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/S1474-4422(22)00009-6","volume":"21","author":"P Benkert","year":"2022","unstructured":"Benkert, P. et al. Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study. Lancet Neurol. 21, 246\u2013257 (2022).","journal-title":"Lancet Neurol."},{"key":"1249_CR31","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2025-1480","author":"EAJ Willemse","year":"2025","unstructured":"Willemse, E. A. J. et al. Serum GFAP as a biomarker for progression in multiple sclerosis: assay comparison and a large reference database of healthy controls. Clin. Chem. Lab. Med. https:\/\/doi.org\/10.1515\/cclm-2025-1480 (2025).","journal-title":"Clin. Chem. Lab. Med."},{"key":"1249_CR32","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000213558","volume":"104","author":"L Kappos","year":"2025","unstructured":"Kappos, L. et al. Composite confirmed disability worsening\/progression is a useful clinical endpoint for multiple sclerosis clinical trials. Neurology 104, e213558 (2025).","journal-title":"Neurology"},{"key":"1249_CR33","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207768","volume":"102","author":"A Cagol","year":"2024","unstructured":"Cagol, A. et al. Association of spinal cord atrophy and brain paramagnetic rim lesions with progression independent of relapse activity in people with MS. Neurology 102, e207768 (2024).","journal-title":"Neurology"},{"key":"1249_CR34","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000210004","volume":"103","author":"JA Reeves","year":"2024","unstructured":"Reeves, J. A. et al. Associations between paramagnetic rim lesion evolution and clinical and radiologic disease progression in persons with multiple sclerosis. Neurology 103, e210004 (2024).","journal-title":"Neurology"},{"key":"1249_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaf433","author":"AM Maceski","year":"2025","unstructured":"Maceski, A. M. et al. GFAP and NfL as predictors of disease progression and relapse activity in fingolimod-treated multiple sclerosis. Brain https:\/\/doi.org\/10.1093\/brain\/awaf433 (2025).","journal-title":"Brain"},{"key":"1249_CR36","doi-asserted-by":"publisher","first-page":"fcaf156","DOI":"10.1093\/braincomms\/fcaf156","volume":"7","author":"S R\u00e4uber","year":"2025","unstructured":"R\u00e4uber, S. et al. Lymphocyte signatures correspond to clinical phenotypes in autoimmune limbic encephalitis. Brain Commun. 7, fcaf156 (2025).","journal-title":"Brain Commun."},{"key":"1249_CR37","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1177\/13524585251375780","volume":"31","author":"S Sandgren","year":"2025","unstructured":"Sandgren, S. et al. Biomarker discovery using nucleic acid-linked immuno-sandwich assay in multiple sclerosis patients experiencing progression independent of relapse activity. Mult. Scler. 31, 1531\u20131542 (2025).","journal-title":"Mult. Scler."},{"key":"1249_CR38","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000214069","volume":"105","author":"G Bsteh","year":"2025","unstructured":"Bsteh, G. et al. Association between retinal layer atrophy with clinical and radiologic progression in people with relapsing multiple sclerosis. Neurology 105, e214069 (2025).","journal-title":"Neurology"},{"key":"1249_CR39","doi-asserted-by":"publisher","first-page":"1407257","DOI":"10.3389\/fneur.2024.1407257","volume":"15","author":"P Zaratin","year":"2024","unstructured":"Zaratin, P. et al. The global patient-reported outcomes for multiple sclerosis initiative: bridging the gap between clinical research and care - updates at the 2023 plenary event. Front. Neurol. 15, 1407257 (2024).","journal-title":"Front. Neurol."},{"key":"1249_CR40","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s40263-017-0412-5","volume":"31","author":"CE van Munster","year":"2017","unstructured":"van Munster, C. E. & Uitdehaag, B. M. Outcome measures in clinical trials for multiple sclerosis. CNS Drugs 31, 217\u2013236 (2017).","journal-title":"CNS Drugs"},{"key":"1249_CR41","unstructured":"FDA patient-focused drug development guidance series for enhancing the incorporation of the patient\u2019s voice in medical product development and regulatory decision making. US FDA https:\/\/www.fda.gov\/drugs\/development-approval-process-drugs\/fda-patient-focused-drug-development-guidance-series-enhancing-incorporation-patients-voice-medical (2025)."},{"key":"1249_CR42","unstructured":"European Medicines Agency. Patient Experience Data (PED) Reflection Paper https:\/\/www.ema.europa.eu\/en\/patient-experience-data-ped-reflection-paper#related-documents-79610 (EMA, 2025)."},{"key":"1249_CR43","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1177\/1352458514564491","volume":"21","author":"RA Marrie","year":"2015","unstructured":"Marrie, R. A. et al. A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview. Mult. Scler. 21, 263\u2013281 (2015).","journal-title":"Mult. Scler."},{"key":"1249_CR44","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nrneurol.2017.33","volume":"13","author":"RA Marrie","year":"2017","unstructured":"Marrie, R. A. Comorbidity in multiple sclerosis: implications for patient care. Nat. Rev. Neurol. 13, 375\u2013382 (2017).","journal-title":"Nat. Rev. Neurol."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01249-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01249-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01249-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T12:01:58Z","timestamp":1790596918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01249-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1249"],"URL":"https:\/\/doi.org\/10.1038\/s41582-026-01249-0","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"assertion":[{"value":"9 July 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}